Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases
Inflammatory bowel diseases (IBD) comprise a distinct set of clinical symptoms resulting from chronic inflammation within the gastrointestinal (GI) tract. Despite the significant progress in understanding the etiology and development of treatment strategies, IBD remain incurable for thousands of pat...
Guardado en:
Autores principales: | Lidiya V. Boldyreva, Maryana V. Morozova, Snezhanna S. Saydakova, Elena N. Kozhevnikova |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ca7f68fc3d274d98b14d5ea15fe7cb46 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Serum Interleukin (IL)-23 and IL-17 Profile in Inflammatory Bowel Disease (IBD) Patients Could Differentiate between Severe and Non-Severe Disease
por: Laura A. Lucaciu, et al.
Publicado: (2021) -
Vaccination against SARS-CoV-2 in Patients with Inflammatory Bowel Diseases: Where Do We Stand?
por: Phil-Robin Tepasse, et al.
Publicado: (2021) -
Epidemiology of Inflammatory Bowel Diseases (IBD) in Iran: A review of 740 patients in Fars province, Southern Iran.
por: John F.Mayberry
Publicado: (2013) -
Frequency of Oral Manifestation in Patients with Inflammatory Bowel Disease in Chile
por: Oviedo,C, et al.
Publicado: (2017) -
The Correlation Between MYO9B Gene Polymorphism and Inflammatory Bowel Disease in the Guangxi Zhuang Population
por: Zeng RZ, et al.
Publicado: (2021)